Innovative Disruption in the World of Neuromuscular Blockade: What Is the "State of the Art?"
From the Department of General Anesthesia, Anesthesiology Institute, Cleveland Clinic, Cleveland, Ohio (M.N.); and Department of Anesthesiology, University of Utah, Salt Lake City, Utah (K.B.J.).
Mohamed
M
Naguib
Ken B
KB
Johnson
D004305:Dose-Response Relationship, Drug; D006801:Humans; D019148:Neuromuscular Blockade; D009469:Neuromuscular Junction; D003473:Neuromuscular Nondepolarizing Agents
D003473:Neuromuscular Nondepolarizing Agents